News for IMCC Stock

IM Cannabis Announces Plans to Voluntarily Delist from the Canadian Securities Exchange IM Cannabis Provides Corporate Updates IM Cannabis Reports First Quarter Financial Results IM Cannabis Announces Filing of Information Circular for Upcoming Annual General and Special Meeting and Provides Additional Information on the Focus Transaction IM Cannabis to Report First Quarter 2025 Financial Results on Thursday, May 15th at 9:00am ET IM Cannabis Provides Corporate Updates IM Cannabis Reports Fourth Quarter and Full Year 2024 Financial Results IM Cannabis to Report Fourth Quarter and Full Year 2024 Financial Results on Monday, March 31 2025 at 9:00am ET IM Cannabis Announces Change of Auditors IM Cannabis Reports Third Quarter Financial Results IM Cannabis to Report Third Quarter 2024 Financial Results on Thursday, November 14th at 9:00am ET IM Cannabis Announces up to US$1,613,000 Private Placement Offering Led by Management IMC Germany Announces Outstanding Preliminary Q3, 2024 Performance with 50% Growth Over Q2 IM Cannabis Announces Appointment of Shmulik Arbel to Board of Directors IM Cannabis Reports Second Quarter Financial Results IM Cannabis to Report Second Quarter 2024 Financial Results on Wednesday, August 14th at 9:00am ET IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement IM Cannabis Shares Commence Trading on 6:1 Consolidated Basis IM Cannabis Announces Intention to Complete Consolidation IMCC Addresses Accelerated Growth in Germany Through new Supply Agreement with EU-GMP Certified Glasshouse Botanics and Announces a Change to its Board of Directors IM Cannabis Closes Convertible Debenture Offering to Support Accelerated Growth in Germany IM Cannabis Reports First Quarter Financial Results IM Cannabis to Report First Quarter 2024 Financial Results on Wednesday, May 8th at 9:00am ET IMC to transfer its Oranim Pharmacy shares back to the seller IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market Avant Brands Bolsters International Growth in German Cannabis Market Through Partnership with IMC Avant and IMC Execute BLK MKT™ Trademark Licensing Agreement for the German Medical Cannabis Market IMC applauds the April 1st implementation of the new Israeli cannabis regulation, facilitating access for many new patients IM Cannabis Reports 2023 Financial Results IMC Expects Accelerated Growth in Germany from the Country's Groundbreaking Cannabis Legalization IM Cannabis to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 28 at 9:00am ET IM Cannabis Receives 180 Calendar Day Extension from the Nasdaq Stock Market to Regain Compliance with Bid Price Rule IMC Reschedules the Final Payment of the Oranim Pharmacy Acquisition IMC Announces the Conclusion of the Planning and Construction Legal Proceedings New Israeli cannabis regulation, facilitating access for many new patients, scheduled for December 29, 2023, has been postponed by three months; Israeli Ministry of Health published a new report showing a surge in new medical cannabis patients in November 2023 IM Cannabis Announces Receipt of Court Action IM Cannabis Reports Third Quarter 2023 Financial Results IM Cannabis to Report Third Quarter 2023 Financial Results on Monday, November 13 at 9:00am ET IM Cannabis Releases a Message from the CEO about the Israel-Hamas War and announces securing C$1,390,000 in Short-Term Debt IM Cannabis Announces the appointment of Uri Birenberg as Chief Financial Officer IM Cannabis Announces CFO Departure IM Cannabis Reports Second Quarter 2023 Financial Results IMC welcomes new Israeli cannabis regulations which are about to change significantly, facilitating access for many new patients IM Cannabis to Report Second Quarter 2023 Financial Results on Monday, August 14 at 9:00am ET IM Cannabis Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement IM Cannabis Reports First Quarter 2023 Financial Results; Gross Profit Increased 46% Year-over-Year IM Cannabis Completes Debt Settlement with L5 Capital IM Cannabis to Report First Quarter 2023 Financial Results on Monday, May 15 at 9:00am ET IM Cannabis Announces Units for Debt Settlement IM Cannabis Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency IM Cannabis Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Revenues in 2022 Increased 60% Year-over-Year IM Cannabis to Report Fourth Quarter & Full Year 2022 Financial Results on Wednesday, March 29 at 9:00am ET IM Cannabis Announces Additional Restructuring Initiatives Designed to Drive Sustainable Profitability and Reduce Costs IM Cannabis Provides an Update on Panaxia Transaction Xinteza Introduces True Water-Soluble Cannabinoids Biosynthesis to Revolutionize Beverages, Cosmetics, and Pharma IM Cannabis Common Shares Commence Trading on Consolidated Basis After 1 for 10 Reverse Stock Split IM Cannabis Reports Third Quarter 2022 Financial Results; Revenues Increased 78% YoY and 12% Sequentially IM Cannabis to Focus on Israel, German and European Growth; Commences Exiting the Canadian Cannabis Market IM Cannabis to Report Third Quarter 2022 Financial Results on Monday, November 14 at 9:00am ET IM Cannabis's Legacy Strain 'Roma' Voted Israel's Favourite Strain of the Month for August 2022 Avant Brands and IM Cannabis Announce the Launch of BLK MKT in Israel Avant Brands and IM Cannabis Announce the Launch of BLK MKT in Israel IM Cannabis Closes Second Tranche of Non-Brokered Private Placement of Common Shares SNDL and IM Cannabis Complete SNDL's First International Export of Premium Dried Flower from Canada to Israel IM Cannabis Welcomes Two New Members to its Board of Directors RAFAEL GABAY ACQUIRES COMMON SHARES OF IM CANNABIS CORP. IM Cannabis Reports Record Second Quarter 2022 Financial Results; Revenues Increase 114% YoY to $23.8 Million Xinteza Unveils Disruptive Non-Cannabaceae Source for Cannabinoid Biosynthesis in Breakthrough Research Led by Prof. Asaph Aharoni at the Weizmann Institute of Science IM Cannabis to Report Second Quarter 2022 Financial Results on Monday, August 15 at 9:00am ET IM Cannabis Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency IM Cannabis Reports Record First Quarter 2022 Financial Results; Revenues Increase 169% YoY to $23.6 Million IM Cannabis to Report First Quarter 2022 Financial Results on Thursday, May 12 at 5:00 p.m. ET OREN SHUSTER ACQUIRES COMMON SHARES OF IM CANNABIS CORP. IM Cannabis Strengthens Focus on Importing Premium and Ultra-Premium Products from its Canadian Subsidiaries IM Cannabis Reports Record Fourth Quarter and Fiscal Year 2021 Financial Results and Provides First Quarter 2022 Outlook IM Cannabis Closes Previously Announced Acquisition of Oranim Pharm, Jerusalem's Leading Medical Cannabis Pharmacy IM Cannabis Reschedules Fourth Quarter and Full Year 2021 Conference Call to Thursday, March 31 at 9:00 a.m. ET IM Cannabis to Report Fourth Quarter and Full Year 2021 Financial Results on Wednesday, March 30 at 9:00 a.m. ET IM Cannabis Closes Three Previously Announced Strategic Acquisitions in Israel IM Cannabis Reports Record Preliminary Fourth Quarter and Full Year 2021 Financial Results IM Cannabis Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program IM Cannabis announces Focus Medical's Import of 400 Kilograms of Premium-Indoor-Grown Dried Cannabis from Canada to Israel IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company’s Israeli Subsidiary IM Cannabis to Launch WAGNERS Brand in Germany IM Cannabis to Acquire Oranim, Jerusalem's Leading Medical Cannabis Pharmacy IM Cannabis Announces Focus Medical's Receipt of Israeli Ministry of Health Import Permit; Plans to Launch WAGNERS Brand in Israel IM Cannabis Announces Fourth Installment of Shares in Connection with the Panaxia Transaction IM Cannabis Announces Third Quarter 2021 Financial Results and Provides Outlook and Business Update IMC Announces Third Installment of Shares in Connection with the Panaxia Transaction IMC Provides Further Details on Panaxia Transaction IM Cannabis Announces Q2 2021 Financial Results and Signing of Definitive Agreement to Acquire Vironna Pharm, Accelerating its Vertical Integration Strategy in Israel IMC Partners with Leading US Brand to Launch cbdMD Products in Israel and Provides Further Details on Panaxia Transaction IMC Announces Results of its Annual General and Special Meeting of Shareholders IMC Accelerates its Israeli Retail Position through Acquisition of Leading Retailer and Distributor Pharm Yarok and Rosen High Way IM Cannabis Provides Update on German Operations and Financial Outlook IM Cannabis Provides Business, Legal and Regulatory Update IM Cannabis Closes Acquisition of MYM Nutraceuticals MYM Shareholders Overwhelmingly Approve Plan of Arrangement with IM Cannabis IM Cannabis Clinical Survey Confirms Effectiveness of Proprietary Strains in Alleviating Symptoms of Seven Key Health Conditions IM Cannabis Announces Supply Agreement with Canadian LP The Flowr Corporation; Plan to Import Ultra-Premium Products as part of Enhanced Portfolio to Meet Growing Israeli Demand IMC Reports First Closing of the Panaxia Acquisition and Provides Update on Canadian Business Activities IM Cannabis Reports Record Q1 2021 Results IM Cannabis Announces Closing of US$ 35 Million Equity Financing IM Cannabis Announces Pricing of Proposed Public Offering of Securities IM Cannabis Announces Proposed Public Offering of Securities IM Cannabis Acquires Israel's Largest Retail and Online Pharmacy Business from Panaxia, Creating a Vertically Integrated Global Platform for the IMC Brand IM Cannabis Reports Fiscal 2020 Results; Provides Preliminary Q1 Results and Q2 Outlook IM Cannabis Provides Update on Adjupharm Business Developments in Germany IM Cannabis to Acquire MYM Nutraceuticals and Its Licensed Producer Subsidiary, Highland Grow IMC Announces Filing of Final Short Form Base Shelf Prospectus IMC Announces Filing of Preliminary Short Form Base Shelf Prospectus IMC to Bring Canadian Premium Indoor High-THC Medical Cannabis to Israel with Imports from GTEC IM Cannabis Corp. Becomes First Israeli Medical Cannabis Operator to list on NASDAQ; Trading Today Under Symbol "IMCC"